Asia · General news · China Daily

Wuxi-developed cancer drug reaches US market

Published by China Daily · China 9 h ago

D3 Bio is advancing four drug candidates through global clinical trials, while Abogen Biosciences signed a licensing agreement with Swiss pharmaceutical giant Novartis in October,…

Read the full article on China Daily Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (global.chinadaily.com.cn)

Also worth reading

The Straits Times

Costa Rica's Grynspan extends lead in informal UN chief poll, sources say

Hindustan Times

Hakeem Jeffries’ ‘private’ meetings with Jared Kushner central to petition against his House speakership

NDTV

Wuxi-developed cancer drug reaches US market

Share

Also worth reading

Costa Rica's Grynspan extends lead in informal UN chief poll, sources say

Hakeem Jeffries’ ‘private’ meetings with Jared Kushner central to petition against his House speakership

Trump Ally Harmeet Dhillon Resigns As Civil Rights Chief After Midterm Rout

Christopher Plummer's widow donates land for 750-acre nature preserve

Hamilton says he won't be silenced, still frustrated after Mexico clash

Peso, stocks stage relief rally on US election results